• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Hookipa Biotech - Articles and news items

HB-101

First-in-human study of CMV vaccine HB-101 starts

Industry news / 20 July 2016 / Victoria White, Digital Content Producer

Hookipa Biotech has announced the start of a first-in-human study to evaluate the safety and immunogenicity of HB-101 against human cytomegalovirus…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +